Injectable Hydrogels of Stimuli-Responsive Elastin and Calmodulin-Based Triblock Copolypeptides for Controlled Drug Release

A variety of block copolypeptides with stimuli responsiveness have been of growing interest for dynamic self-assembly. Here, multistimuli-responsive triblock copolypeptides composed of thermosensitive elastin-based polypeptides (EBP) and ligand-responsive calmodulin (CalM) were genetically engineere...

Full description

Saved in:
Bibliographic Details
Published inBiomacromolecules Vol. 23; no. 5; pp. 2051 - 2063
Main Authors Lee, Jae Sang, Kang, Min Jeong, Lee, Jae Hee, Lim, Dong Woo
Format Journal Article
LanguageEnglish
Published United States 09.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A variety of block copolypeptides with stimuli responsiveness have been of growing interest for dynamic self-assembly. Here, multistimuli-responsive triblock copolypeptides composed of thermosensitive elastin-based polypeptides (EBP) and ligand-responsive calmodulin (CalM) were genetically engineered, over-expressed, and nonchromatographically purified by inverse transition cycling. Diluted EBP-CalM-EBP (ECE) triblock copolypeptides under physiological conditions self-assembled into vesicles at the nanoscale by temperature-triggered aggregation of the EBP block with lower critical solution temperature behaviors. Furthermore, concentrated ECE triblock copolypeptides under identical conditions exhibited thermally induced gelation, resulting in physically crosslinked hydrogels. They showed controlled rheological and mechanical properties depending on the conformational change of the CalM middle block induced by binding either Ca or Ca and trifluoperazines (TFPs) as ligands. In addition, both Ca -free and Ca -bound ECE triblock copolypeptide hydrogels exhibited biocompatibility, while those bound to both Ca and TFPs showed severe cytotoxicity because of controlled TFP release of the CalM blocks. The ECE triblock hydrogels with stimuli responsiveness would be useful as injectable drug delivery depots for biomedical applications.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1525-7797
1526-4602
DOI:10.1021/acs.biomac.2c00053